Wealth Alliance Edwards Lifesciences Corp Transaction History

Wealth Alliance

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$84.3 - $94.31 $11,043 - $12,354	131 Added 5.64%	2,453 $226,000
Q1 2024 May 10, 2024	BUY	$72.54 - $95.56 $168,437 - $221,890	2,322 New	2,322 $221,000
Q2 2023 Aug 02, 2023	SELL	$81.41 - $94.33 $2,930 - $3,395	-36 Reduced 1.27%	2,805 $264,000
Q1 2023 May 10, 2023	BUY	$74.26 - $84.51 $210,972 - $240,092	2,841 New	2,841 $235,000
Q2 2022 Oct 11, 2022	BUY	$86.5 - $128.27 $209,416 - $310,541	2,421 New	2,421 $230,000

1,354

469M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $44.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Wealth Alliance, based on Form 13F filings with the SEC.

Stay updated on Wealth Alliance with notifications on news.